Hamilton Lane Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,789
Closed -$394K 100
2021
Q2
$394K Sell
8,789
-55,514
-86% -$2.57M 0.12% 66
2021
Q1
$3.23M Buy
+64,303
New +$4.38M 1.05% 23

Other funds holding CELL

Hamilton Lane Advisors's CELL Position: Q3 2021 in Review

Hamilton Lane Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 8,789 shares — an estimated $394K sold.

Hamilton Lane Advisors first reported a position in CELL in Q1 2021 and held it in 2 quarters. The position peaked at $3.23M in Q1 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Hamilton Lane Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Hamilton Lane Advisors sold 8,789 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $394K.
  • Hamilton Lane Advisors first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Hamilton Lane Advisors's PhenomeX Inc. Common Stock position peaked at $3.23M in Q1 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Hamilton Lane Advisors's 13F filing for Q3 2021, filed 14 Oct 2021.